Free Trial

Scienture Q2 2023 Earnings Report

$7.58 -0.55 (-6.77%)
(As of 12/20/2024 05:16 PM ET)

Scienture EPS Results

Actual EPS
-$0.77
Consensus EPS
-$0.75
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

Scienture Revenue Results

Actual Revenue
$2.25 million
Expected Revenue
$2.06 million
Beat/Miss
Beat by +$190.00 thousand
YoY Revenue Growth
N/A

Scienture Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Scienture? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scienture and other key companies, straight to your email.

About Scienture

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

View Scienture Profile

More Earnings Resources from MarketBeat

Upcoming Earnings